Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu V Chakravarthy

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|May 19, 2010
Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosisJochen G Schneider, Zhen Yang, Manu V Chakravarthy, et al.
Cell Metabolism|August 2, 2005
"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasisManu V Chakravarthy, Zhijun Pan, Yimin Zhu, et al.
Scientific Reports|June 5, 2021
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell modelsNadine Daou, Andreu Viader, Murat Cokol, et al.
Cell|August 4, 2009
Identification of a physiologically relevant endogenous ligand for PPARalpha in liverManu V Chakravarthy, Irfan J Lodhi, Li Yin, et al.
Journal of Lipid Research|November 26, 2008
Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammationManu V Chakravarthy, Yimin Zhu, Li Yin, et al.
The Journal of Biological Chemistry|November 25, 2010
De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylationXiaochao Wei, Jochen G Schneider, Sherene M Shenouda, et al.
Diabetes|July 2, 2008
Decreased fetal size is associated with beta-cell hyperfunction in early life and failure with ageManu V Chakravarthy, Yimin Zhu, Mitchell B Wice, et al.
Frontiers in Endocrinology|February 15, 2021
Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic SteatohepatitisAndrea Dennis, Matt D Kelly, Carolina Fernandes, et al.
The American Journal of Gastroenterology|August 12, 2021
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver DiseaseStephen A Harrison, Seth J Baum, Nadege T Gunn, et al.
The Journal of Clinical Investigation|August 19, 2007
Brain fatty acid synthase activates PPARalpha to maintain energy homeostasisManu V Chakravarthy, Yimin Zhu, Miguel López, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|May 19, 2010
Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosisJochen G Schneider, Zhen Yang, Manu V Chakravarthy, et al.
Cell Metabolism|August 2, 2005
"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasisManu V Chakravarthy, Zhijun Pan, Yimin Zhu, et al.
Scientific Reports|June 5, 2021
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell modelsNadine Daou, Andreu Viader, Murat Cokol, et al.
Cell|August 4, 2009
Identification of a physiologically relevant endogenous ligand for PPARalpha in liverManu V Chakravarthy, Irfan J Lodhi, Li Yin, et al.
Journal of Lipid Research|November 26, 2008
Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammationManu V Chakravarthy, Yimin Zhu, Li Yin, et al.
The Journal of Biological Chemistry|November 25, 2010
De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylationXiaochao Wei, Jochen G Schneider, Sherene M Shenouda, et al.
Diabetes|July 2, 2008
Decreased fetal size is associated with beta-cell hyperfunction in early life and failure with ageManu V Chakravarthy, Yimin Zhu, Mitchell B Wice, et al.
Frontiers in Endocrinology|February 15, 2021
Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic SteatohepatitisAndrea Dennis, Matt D Kelly, Carolina Fernandes, et al.
The American Journal of Gastroenterology|August 12, 2021
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver DiseaseStephen A Harrison, Seth J Baum, Nadege T Gunn, et al.
The Journal of Clinical Investigation|August 19, 2007
Brain fatty acid synthase activates PPARalpha to maintain energy homeostasisManu V Chakravarthy, Yimin Zhu, Miguel López, et al.
Pageof 3